Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Tamsulosin (0.4mg) + Finasteride (5mg)
Therapeutic Category
General and OTC medicines, Urology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹140/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Uriviga F MR Tablet is a combination therapy containing Tamsulosin (0.4mg) and Finasteride (5mg), specifically designed to manage the symptoms of benign prostatic hyperplasia (BPH). This medication offers dual-action relief by addressing the root causes of prostate enlargement and urinary discomfort:
This combination provides effective long-term management of BPH by relieving symptoms like frequent urination, difficulty in starting urination, and weak stream while simultaneously slowing prostate growth.
Possible side effects include headache, nausea, abdominal pain, and diarrhea. Long-term use may lead to vitamin B12 deficiency and bone fractures.
Ribziff 20 Injection is used for the treatment of gastroesophageal reflux disease (GERD), gastritis, and peptic ulcers. It is also used in combination therapy to eradicate Helicobacter pylori infection.
For intravenous use only. Administer under medical supervision, and do not exceed the recommended dose.
Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.
Composition : Warfarin 1 mg tablet
Composition : Warfarin 2 mg tablet
Composition : Warfarin 5 mg tablet
Composition : Dabigatran 110 mg etexilate capsules
Composition : Heparin (5000IU) + Benzyl Alcohol (0.95%) Injection
Composition : Apixaban 2.5 MG Tablet
Composition : Apixaban 5 MG Tablet
Composition : Dabigatran 75 mg Capsule
Composition : Nicoumalone 3mg Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.